Quality of life in participants of a CRC screening program

British Journal of Cancer

Volumn 107, Issue 8, 2012, Pages 1295-1301

  Kapidzic, A ^a   Korfage, I J ^a   Van Dam, L ^a   Van Roon, A H C ^a   Reijerink, J C I Y ^b   Zauber, A G ^c   Van Ballegooijen, M ^b   Kuipers, E J ^a   Van Leerdam, M E ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Association of Nationwide Screening South western Netherlands   (Netherlands)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Colorectal cancer screening; Faecal immunochemical test; Flexible sigmoidoscopy; Quality of life; Screen specific anxiety

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; CANCER SCREENING; CLINICAL TRIAL (TOPIC); COLORECTAL CANCER; CONTROLLED STUDY; FECAL IMMUNOCHEMICAL TEST; FECES ANALYSIS; FEMALE; HEALTH PROGRAM; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SIGMOIDOSCOPY; STATISTICAL SIGNIFICANCE;

AGED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOCHEMISTRY; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SIGMOIDOSCOPY;

EID: 84867396104     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.386     Document Type: Article

References (27)

1. Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, Parkin DM, Wardle J, Duffy SW, Cuzick J, Investigators, U.K.F.S.T. (2010) Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 375: 1624-1633
2. Brasso K, Ladelund S, Frederiksen BL, Jorgensen T (2010) Psychological distress following fecal occult blood test in colorectal cancer screening-a population-based study. Scand J Gastroenterol 45: 1211-1216
3. Center MM, Jemal A, Smith RA, Ward E (2009) Worldwide variations in colorectal cancer. CA Cancer J Clin 59: 366-378
4. Dolan P (1997) Modeling valuations for EuroQol health states. Med Care 35: 1095-1108 (Pubitemid 127453463)
5. Essink-Bot ML, de Koning HJ, Nijs HG, Kirkels WJ, van der Maas PJ, Schroder FH (1998) Short-term effects of population-based screening for prostate cancer on health-related quality of life. J Natl Cancer Inst 90: 925-931 (Pubitemid 28304162)
6. Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M (1998) Crossvalidation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 51: 1171-1178 (Pubitemid 28527173)
7. Gramling R, Anthony D, Frierson G, Bowen D (2007) The cancer worry chart: a single-item screening measure of worry about developing breast cancer. Psychooncology 16: 593-597 (Pubitemid 47039561)
8. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L (2008) Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 103: 1541-1549 (Pubitemid 351813919)
9. Hoff G, Grotmol T, Skovlund E, Bretthauer M, Norwegian Colorectal Cancer Prevention Study, G (2009) Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ 338: b1846
10. Hol L, van Leerdam ME, van Ballegooijen M, van Vuuren AJ, van Dekken H, Reijerink JC, van der Togt AC, Habbema JD, Kuipers EJ (2010) Screening for colorectal cancer: randomised trial comparing guaiacbased and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 59: 62-68
11. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90
12. Korfage IJ, van Ballegooijen M, Huveneers H, Essink-Bot ML (2010) Anxiety and borderline PAP smear results. Eur J Cancer 46: 134-141
13. Lindholm E, Berglund B, Kewenter J, Haglind E (1997) Worry associated with screening for colorectal carcinomas. Scand J Gastroenterol 32: 238-245 (Pubitemid 27105299)
14. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F (1993) Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328: 1365-1371 (Pubitemid 23131388)
15. Millar K, Jelicic M, Bonke B, Asbury AJ (1995) Assessment of preoperative anxiety: comparison of measures in patients awaiting surgery for breast cancer. Br J Anaesth 74: 180-183
16. Nicholson FB, Barro JL, Atkin W, Lilford R, Patnick J, Williams CB, Pignone M, Steele R, Kamm MA (2005) Review article: population screening for colorectal cancer. Aliment Pharmacol Ther 22: 1069-1077 (Pubitemid 41779514)
17. Norman GR, Sloan JA, Wyrwich KW (2003) Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 41: 582-592
18. Parker MA, Robinson MH, Scholefield JH, Hardcastle JD (2002) Psychiatric morbidity and screening for colorectal cancer. J Med Screen 9: 7-10 (Pubitemid 34327135)
19. Pizzo E, Pezzoli A, Stockbrugger R, Bracci E, Vagnoni E, Gullini S (2011) Screenee perception and health-related quality of life in colorectal cancer screening: a review. Value Health 14: 152-159
20. Rijnsburger AJ, Essink-Bot ML, van As E, Cockburn J, de Koning HJ (2006) Measuring psychological consequences of screening: adaptation of the psychological consequences questionnaire into Dutch. Qual Life Res 15: 933-940 (Pubitemid 43800764)
21. Statistics Netherlands (2010) Health, Lifestyle, Use of Medical Facilities. Centraal Bureau voor de Statistiek: Den Haag/Heerlen, The Netherlands
22. Sutton S, Saidi G, Bickler G, Hunter J (1995) Does routine screening for breast cancer raise anxiety? Results from a three wave prospective study in England. J Epidemiol Community Health 49: 413-418
23. Taupin D, Chambers SL, Corbett M, Shadbolt B (2006) Colonoscopic screening for colorectal cancer improves quality of life measures: a population-based screening study. Health Qual Life Outcomes 4: 82
24. Taylor KL, Shelby R, Gelmann E, McGuire C (2004) Quality of life and trial adherence among participants in the prostate, lung, colorectal, and ovarian cancer screening trial. J Natl Cancer Inst 96: 1083-1094 (Pubitemid 39172410)
25. Thiis-Evensen E, Wilhelmsen I, Hoff GS, Blomhoff S, Sauar J (1999) The psychologic effect of attending a screening program for colorectal polyps. Scand J Gastroenterol 34: 103-109 (Pubitemid 29074795)
26. van Roon AH, Goede SL, van Ballegooijen M, van Vuuren AJ, Looman CW, Biermann K, Reijerink JC, Mannetje HT, van der Togt AC, Habbema JD, van Leerdam ME, Kuipers EJ (2012) Random comparison of repeated faecal immunochemical testing at different intervals for population-based colorectal cancer screening. Gut; doi:10.1136/gutjnl-2011-301583
27. Ware JEJ, Snow KK, Kosinski M, Gandek BG (1993) SF-36 Health Survey: Manual and Interpretation Guide. The Health Institute, New England Medical Center: Boston, M.A.